KU

Kiranbhai Upendrabhai Pandit

Director Director DIN 08285034
DIN 08285034 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Kiranbhai Upendrabhai Pandit

Data last updated:

Kiranbhai Upendrabhai Pandit was a Director at Trulexa Wellness Private Limited (2018–2020). The company operates in Pharma.

DIN 08285034
Primary Designation Director
Industry Pharma
First Appointment 23 Nov 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trulexa Wellness Private Limited U74994GJ2018PTC105133
Director23 Nov 20182018₹66.9 Lakh (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Trulexa Wellness Private Limited
Premium access

Shareholding and investment profile for Kiranbhai Upendrabhai Pandit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiranbhai Upendrabhai Pandit

Kiranbhai Upendrabhai Pandit was first appointed on 23 Nov 2018 as Director at Trulexa Wellness Private Limited.

Kiranbhai Upendrabhai Pandit held 1 earlier board appointment: Trulexa Wellness Private Limited (Director, 23 Nov 2018 to 02 Apr 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available